2024 Update from Ronny Allan: Reassuringly stable!

• Facebook
• X
• Bluesky
• Pinterest
• Threads
• WhatsApp
• Mail

In every surveillance session I’ve had since diagnosis, there was always something to report.  Much of it was old stuff that had been there since diagnosis which they are tracking (incidental findings).  However, there is also stuff that they know is almost certainly NET but not doing much and not threatening me.  That sentence alone probably translates to “stable“.

After a surveillance event in 2021, I was awarded the accolade of “reassuringly stable“, a status which I was happy to accept! In 2022, despite evidence of disease, I was stable!  In 2023, I was given the headline of “No evidence of progressive disease at any site” (i.e. stable).

Words are very important to cancer patients, some people hang their hats on them and put their feet up, and some people google them until they are tied in a knot, still fraught with worry.  Why can’t doctors just tell me in layman’s language?  Easy answer ……. because it is not an exact science. Doctors are not robots (…… yet!), they are human beings just like us.  Doctors have different views; some doctors have better patient communication.  They don’t have crystal balls, but they do really care and sometimes that’s what matters more.   Read my post “Cure vs Remission vs No Evidence of Disease (NED)“.

The title of this blog post sounds like a bit of a conundrum, some might call it an oxymoron.  How can I be stable but with evidence of disease (ED)?  I’m sure there are some people (including other patients) who think I should get my doctors to search out the remnant disease and then cut it, burn it freeze it, or poison it. Whatever you do, just get rid of it.  It’s not as simple as that, if you try to get every single speck of disease, you may not have much tissue left and you may reduce your quality of life. I’m happy to wait until they tell me it’s something threatening my mortality and/or my quality of life.

I see so many individual and differing points of view in my private Facebook group, it just confirms my own view that this is not an exact science.  But also, we are all different shades of NET, just like NET doctors.

p.s. I love to hear people being declared “NED” or “stable”.

For now, I’ll continue with my ‘ED’ label and crack on with life.  After all, I’ve been stable with ‘ED’ for 11 years now! 

Disclaimer

I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me.

Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional.

Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.

Click here and answer all questions to join my private Facebook group


Facebook


Twitter


WordPress


Instagram

Thanks for reading.

Ronny

Check out my WEGO Health Awards

Check out my Glossary of Terms – click here

Please Share this post for Neuroendocrine Cancer awareness and to help another patient

• 
  Neuroendocrine Tumours (NETs) – Vitamin D (Cholecalciferol / Ergocalciferol)March 17, 2026
  Vitamin D deficiency is demonstrably more common in people with neuroendocrine tumours (NETs) — but that does not automatically mean your deficiency is caused by your NET. Vitamin D deficiency is widespread in the general population, particularly in northern latitudes, older adults, and people with limited sun exposure. However, NET patients accumulate multiple, well‑recognised risk factors,… Read more: Neuroendocrine Tumours (NETs) – Vitamin D (Cholecalciferol / Ergocalciferol)
• 
  Cancer: Words are important but so is contextMarch 11, 2026
  Words are very important to cancer patients, some people hang their hats on them and put their feet up, and some people google them until they are tied in a knot, still fraught with worry.  Why can’t doctors just tell me in layman’s language?  Easy answer ……. because it is not an exact science. Doctors… Read more: Cancer: Words are important but so is context
• 
  Newsletter covering January and February 2026March 1, 2026
  Overview Many thanks for the support in January and February 2026.  This is a double month newsletter due to my 27 day holiday! 2026 Blog Activity for January and February Actually, despite my  holiday figures are pretty much normal.  I had a great month in December 2025, perhaps I was overperforming as I was anticipating… Read more: Newsletter covering January and February 2026
• 
  Neuroendocrine Tumours (NET) – Vitamin B12 (Cobalamin)February 27, 2026
  Vitamin B12 deficiency is demonstrably more common in people with neuroendocrine tumours (NETs) – what that means is there is a chance your deficiency as a NET patients may not be related to your NET.  However, it’s a fairly common comorbidity reported in NET patients and it’s important to note the mechanisms differ by primary… Read more: Neuroendocrine Tumours (NET) – Vitamin B12 (Cobalamin)
• 
  Sometimes you gotta climb that bridge!February 18, 2026
  When I was a young lad, I didn’t seem to have a fear of heights, not that I got many chances to test it but a couple of things springs to mind.  As a ‘feral youth’ I once climbed to the top of a factory building without fear.  I won’t divulge any further detail, just… Read more: Sometimes you gotta climb that bridge!
• 
  50 years of marriage – in sickness and in healthFebruary 10, 2026
  When I was diagnosed with metastatic Neuroendocrine Cancer in 2010, there’s a lot of milestones I doubted I would reach. One is today and I can now tick off another and be thankful for reaching it. I have been married to a kind and beautiful lady for 50 years on – 29th March 2025. I’ve… Read more: 50 years of marriage – in sickness and in health
• 
  Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors (STELLAR-311)February 6, 2026
  A Phase 2/3, Multicenter, Randomized Open-Label Study of Zanzalintinib vs Everolimus in Participants With Previously Treated, Unresectable, Locally Advanced or Metastatic Neuroendocrine Tumors.  The primary purpose of this study is to assess the effectiveness of zanzalintinib compared to everolimus in participants with previously treated, unresectable, locally advanced or metastatic neuroendocrine tumors. Zanzalintinib (XL092) is an investigational,… Read more: Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors (STELLAR-311)
• 
  Next Generation Total-Body PET/CT: Challenges and OpportunitiesJanuary 13, 2026
  Long-axial field-of-view (LAFOV) systems have changed the field of molecular imaging. Since their introduction, many PET centres have installed these next-generation digital systems to provide more detailed imaging and acquire PET images in a single bed position. Indeed, vertex to thigh imaging for oncological indications can be obtained in most of the population with the… Read more: Next Generation Total-Body PET/CT: Challenges and Opportunities
• 
  Phase 1/2 Trial Evaluating CRN09682 for the Treatment of Neuroendocrine Tumors and Other Somatostatin Receptor 2-Expressing TumorsJanuary 5, 2026
  Crinetics Announces First Patient Dosed in Phase 1/2 Trial Evaluating CRN09682 for the Treatment of Neuroendocrine Tumours and Other Somatostatin Receptor 2-Expressing Tumours Read the news – click here Clinical Trial Document – click here Limited to US (6 locations) (so far). CRN09682, a first‑in‑class non‑peptide drug conjugate (NDC) developed by Crinetics Pharmaceuticals. The company… Read more: Phase 1/2 Trial Evaluating CRN09682 for the Treatment of Neuroendocrine Tumors and Other Somatostatin Receptor 2-Expressing Tumors
• 
  Ronny Allan – a review of my blog activity December 2025January 2, 2026
  Here is the monthly summary of December 2025 on RonnyAllan.NET – Every share helps someone understand or even work towards a diagnosis, discovery of the best doctors and treatments. December is normally a quiet month, often the quietist month of the year.  However, this year, it was the best figures for the whole of 2025. … Read more: Ronny Allan – a review of my blog activity December 2025
• 
  A review of 2025 on RonnyAllan.NETDecember 30, 2025
  Summary of 2025 from Ronny  It was a good year for my advocacy work but a difficult year personally which had some impact on my advocacy work.  I had to spend quite a bit of time looking after my brother’s affairs when he was diagnosed with dementia and is now living in residential care. That… Read more: A review of 2025 on RonnyAllan.NET
• 
  15 years of Christmas!December 24, 2025
  15 Christmas celebrations since diagnosis. A thankful statement My Facebook memories today are full of Christmas activities including my first Christmas following diagnosis of advanced Neuroendocrine Cancer.  I had been out of hospital for only 4 weeks following major surgery in 2010. I remember the whole of my own family attended, my son and daughter’s… Read more: 15 years of Christmas!
• 
  Another Next Generation PET/CT is coming soon. The Omni 128cm Total Body PET – Small Australian trial at Peter MacDecember 17, 2025
  A Global first for NET.  Omni 128cm Total Body PET at the Peter MacCallum Cancer Centre in Melbourne Australia.  According to Professor Michael Hofman, they have been using the camera for a couple weeks and it is exceeding their expectations.  They’re running a short trial comparing results against regular PETs.  The great news is that… Read more: Another Next Generation PET/CT is coming soon. The Omni 128cm Total Body PET – Small Australian trial at Peter Mac
• 
  Neuroendocrine Cancer: I hadn’t heard of it until I was diagnosed with itDecember 14, 2025
  My diagnosis came with many strange words including, “carcinoid” and “neuroendocrine” ……… can you spell that please, I said to the doctor. I had a low ki67 figure from a tissue sample taken percutaneously from my liver, it seemed pretty good that I was only 5 in a range of 0-100 but somehow the word… Read more: Neuroendocrine Cancer: I hadn’t heard of it until I was diagnosed with it